Viva Biotech Overview
- Status
-
Public
- Employees
-
2,213
- Stock Symbol
-
01873
- Investments
-
42
- Share Price
-
$0.14
- (As of Friday Closing)
Viva Biotech General Information
Description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact Information
Website
www.vivabiotech.comCorporate Office
- Number 735 Ziping Road, Pudong New Area
- Shanghai, 201318
- China
Corporate Office
- Number 735 Ziping Road, Pudong New Area
- Shanghai, 201318
- China
Viva Biotech Timeline
Viva Biotech Stock Performance
As of 20-Nov-2026, Viva Biotech’s stock price is $0.14. Its current market cap is $299M with 2.09B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.14 | $0.15 | $0.13 - $0.37 | $299M | 2.09B | 4.64M | $0.01 |
Viva Biotech Financials Summary
As of 30-Jun-2026, Viva Biotech has a trailing 12-month revenue of $272M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 334,695 | 525,475 | 308,518 | 541,177 |
| Revenue | 272,116 | 240,491 | 276,867 | 304,681 |
| EBITDA | 68,208 | 76,432 | 75,663 | 42,636 |
| Net Income | 25,443 | 30,559 | 23,315 | (16,412) |
| Total Assets | 1,014,445 | 1,028,945 | 965,822 | 1,050,971 |
| Total Debt | 132,187 | 190,173 | 175,895 | 268,490 |
Viva Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Viva Biotech Comparisons
Industry
Financing
Details
Viva Biotech Competitors (2)
One of Viva Biotech’s 2 competitors is 3Sbio, a Formerly PE-Backed company based in Shenyang, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 3Sbio | Formerly PE-Backed | Shenyang, China | ||||
| Asymchem | Formerly VC-backed | Tianjin, China |
Viva Biotech Patents
Viva Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024031791-A1 | Sample cryopreservation device for cryo-scanning electron microscope | Inactive | 10-Aug-2022 | ||
| WO-2024021269-A1 | Cryo-stage for cryo-electron microscope and control system therefor | Inactive | 28-Jul-2022 | ||
| US-20240424113-A1 | Conjugates comprising antifungals and heat shock protein 90 (hsp90) inhibitors and methods of use thereof | Pending | 19-Oct-2021 | ||
| US-10329298-B2 | Inhibitors of cellular metabolic processes | Inactive | 22-Aug-2017 | ||
| US-20180079753-A1 | Inhibitors of cellular metabolic processes | Active | 22-Aug-2017 | C07D487/04 |
Viva Biotech Signals
Viva Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Viva Biotech Investments & Acquisitions (42)
Viva Biotech’s most recent deal was a Secondary Transaction - Private with Langhua Pharmaceutical for . The deal was made on 21-Sep-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Langhua Pharmaceutical | 21-Sep-2023 | Secondary Transaction - Private | BPO/Outsource Services | ||
| Triumvira | 21-Sep-2022 | Later Stage VC | Biotechnology | ||
| Apeiron (Drug Discovery) | 29-Mar-2022 | Early Stage VC | Drug Discovery | ||
| BioCast Pharmaceutical | 29-Nov-2021 | Early Stage VC | BPO/Outsource Services | ||
| Full Circles Therapeutics | 01-Nov-2021 | Early Stage VC | Biotechnology |
Viva Biotech ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.69 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Viva Biotech Exits (22)
Viva Biotech’s most recent exit was on 08-Jun-2021 from Gen House. The exit was categorized as with 7 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Gen House | 08-Jun-2021 | Completed |
|
||
| Riparian Pharmaceuticals | 01-Apr-2021 | Completed |
|
||
| DTx Pharma | 21-Mar-2021 | Completed |
|
||
| Focus-X Therapeutics | 10-Mar-2021 | Completed |
|
||
| Argonaut Genomics | 01-Feb-2021 | Accelerator/Incubator | Completed |
Viva Biotech Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SYNthesis ( | Parkville, Australia | 2007 | |
| Langhua Pharmaceutical | Taizhou, China | 2000 |
Viva Biotech FAQs
-
Where is Viva Biotech headquartered?
Viva Biotech is headquartered in Shanghai, China.
-
What is the size of Viva Biotech?
Viva Biotech has 2,213 total employees.
-
What industry is Viva Biotech in?
Viva Biotech’s primary industry is Drug Discovery.
-
Is Viva Biotech a private or public company?
Viva Biotech is a Public company.
-
What is Viva Biotech’s stock symbol?
The ticker symbol for Viva Biotech is 01873.
-
What is the current stock price of Viva Biotech?
As of 20-Nov-2026 the stock price of Viva Biotech is $0.14.
-
What is the current market cap of Viva Biotech?
The current market capitalization of Viva Biotech is $299M.
-
What is Viva Biotech’s current revenue?
The trailing twelve month revenue for Viva Biotech is $272M.
-
Who are Viva Biotech’s competitors?
-
What is Viva Biotech’s annual earnings per share (EPS)?
Viva Biotech’s EPS for 12 months was $0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process